These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9807954)

  • 1. External beam radiotherapy in the management of subfoveal choroidal neovascular membranes of the eye: a new treatment for an old disease.
    Archer DB
    Ulster Med J; 1998 Jun; 67 Suppl 1(Suppl 1):41-6. PubMed ID: 9807954
    [No Abstract]   [Full Text] [Related]  

  • 2. External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration: one-year results of a prospective, double-masked, randomized clinical trial.
    Marcus DM; Sheils W; Johnson MH; McIntosh SB; Leibach DB; Maguire A; Alexander J; Samy CN
    Arch Ophthalmol; 2001 Feb; 119(2):171-80. PubMed ID: 11176977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton beam irradiation of subfoveal choroidal neovascularisation in age-related macular degeneration.
    Flaxel CJ; Friedrichsen EJ; Smith JO; Oeinck SC; Blacharski PA; Garcia CA; Chu HH
    Eye (Lond); 2000 Apr; 14 ( Pt 2)():155-64. PubMed ID: 10845009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton beam irradiation for neovascular age-related macular degeneration.
    Zambarakji HJ; Lane AM; Ezra E; Gauthier D; Goitein M; Adams JA; Munzenrider JE; Miller JW; Gragoudas ES
    Ophthalmology; 2006 Nov; 113(11):2012-9. PubMed ID: 16935343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton beam irradiation for non-AMD CNV: 2-year results of a randomised clinical trial.
    Chen L; Kim IK; Lane AM; Gauthier D; Munzenrider JE; Gragoudas ES; Miller JW
    Br J Ophthalmol; 2014 Sep; 98(9):1212-7. PubMed ID: 24820046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of radiotherapy of subfoveal neovascularization with 16 and 20 Gy.
    Hoeller U; Fuisting B; Schwartz R; Roeper B; Richard G; Alberti W
    Eye (Lond); 2005 Nov; 19(11):1151-6. PubMed ID: 15543182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-associated choroidal neovasculopathy.
    Spaide RF; Leys A; Herrmann-Delemazure B; Stalmans P; Tittl M; Yannuzzi LA; Burke KM; Fisher YL; Freund KB; Guyer DR; Slakter JS; Sorenson JA
    Ophthalmology; 1999 Dec; 106(12):2254-60. PubMed ID: 10599654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External beam radiation therapy for CNV.
    Hawkins WR
    Ophthalmology; 1998 Oct; 105(10):1789-90. PubMed ID: 9787338
    [No Abstract]   [Full Text] [Related]  

  • 9. External beam radiation therapy for CNV.
    Chakravarthy U; Hart P; Finger P
    Ophthalmology; 1998 Oct; 105(10):1790-1; author reply 1791-2. PubMed ID: 9787339
    [No Abstract]   [Full Text] [Related]  

  • 10. Verteporfin photodynamic therapy for the treatment of persistent subfoveal choroidal neovascularization after external beam radiotherapy: one-year results.
    Gupta R; Browning AC; Wu K; Sokal M; Amoaku WM
    Am J Ophthalmol; 2005 Mar; 139(3):561-2. PubMed ID: 15767080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late side-effects of radiotherapy for subfoveal choroidal neovascularization.
    Postelmans L; Bozkurt E; Verougstraete C; Leys A
    Bull Soc Belge Ophtalmol; 1999; 271():61-8. PubMed ID: 10355162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of age-related subfoveal neovascular membranes by teletherapy: results of a non-randomized study.
    Subaşi M; Akmansu M; Or M
    Radiat Med; 1999; 17(2):169-73. PubMed ID: 10399787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of trans-scleral diode laser using diopexy probe for subfoveal choroidal neovascular membrane in age-related macular degeneration.
    Venkatesh P; Gupta RK; Verma L; Tewari HK
    J Clin Laser Med Surg; 2004 Apr; 22(2):91-7. PubMed ID: 15165382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. It is not time to abandon radiotherapy for neovascular age-related macular degeneration.
    Fine SL; Maguire MG
    Arch Ophthalmol; 2001 Feb; 119(2):275-6. PubMed ID: 11176992
    [No Abstract]   [Full Text] [Related]  

  • 15. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD.
    Avila MP; Farah ME; Santos A; Kapran Z; Duprat JP; Woodward BW; Nau J
    Retina; 2009 Feb; 29(2):157-69. PubMed ID: 19202425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy with verteporfin for subfoveal choroidal neovascular membranes in highly myopic eyes after laser in situ keratomileusis.
    Arevalo JF; Ruiz-Moreno JM; Fernandez CF; Mendoza AJ; Ramirez E; Montero JA
    Ophthalmic Surg Lasers Imaging; 2004; 35(1):58-62. PubMed ID: 14750766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiotherapy for choroidal neovascularization (CNV) in age-related macular degeneration (AMD)].
    Thölen AM; Meister A; Bernasconi PP; Messmer EP
    Klin Monbl Augenheilkd; 2000 Feb; 216(2):112-5. PubMed ID: 10730228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2.
    Stevenson MR; Hart PM; Chakravarthy U; Mackenzie G; Bird AC; Owens SL; Chisholm IH; Hall V; Houston RF; McCulloch DW; Plowman N
    Br J Ophthalmol; 2005 Aug; 89(8):1045-51. PubMed ID: 16024863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical removal of non-age-related subfoveal choroidal neovascular membranes.
    Eckstein M; Wells JA; Aylward B; Gregor Z
    Eye (Lond); 1998; 12 ( Pt 5)():775-80. PubMed ID: 10070507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The age-related macular degeneration radiotherapy trial (AMDRT): one year results from a pilot study.
    Marcus DM; Peskin E; Maguire M; Weissgold D; Alexander J; Fine S; Followill D;
    Am J Ophthalmol; 2004 Nov; 138(5):818-28. PubMed ID: 15531318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.